Membrane Affinity and Metabolism of A/4-Palmitoyl-1-/?-D-Arabinofuranosylcytosine into Cultured KB Cells1

A/4-Palmitoyl-1 -/8-D-arabinofuranosylcytosine (/V4-palmitoyl-ara-C), a lipophilic derivative of 1-yß-D-arabinofuranosylcyto-sine, possessed an affinity for KB cell plasma membrane. Approximately 15 to 25% of the drug incorporated into KB cells was retained in plasma membrane when the cells were treated with the drug for 1 to 32 hr at 10 ¡IM,the concentration required for 50% inhibition of cell growth. Less than 5.3% of the drug was found in the plasma membrane when the cells were treated with 1-ß-D-arabinofuranosylcytosine. W-Palmi-toyl-ara-C in the membrane fraction cosedimented with plasma membrane in a sucrose density gradient at 4°, indicating a close association between the drug and the membrane. The affinity of W-palmitoyl-ara-C for plasma membrane probably contributes to the efficient uptake rate and the strong cytotoxic effect of /V'-palmitoyl-ara-C reported previously. The metabolites of /\/4-palmitoyl-ara-C in KB cells, treated with the drug for 32 hr at the concentration required for 50% inhibition of cell growth (10 ¡IM),were analyzed by diethyl-aminoethyl Sepharose CL-6B column chromatography thin-layer and paper chromatography. This analysis showed that over 98% of the drug present in the KB cell was A/4-palmitoyl-ara-C. The active metabolites, 1-/S-D-arabinofurano- sylcytosine, 1-/?-D-arabinofuranosylcytosine 5'-monophos-phate, A/4-palmitoyl-1-/?-D-arabinofuranosylcytosine 5'-mono-phosphate, and 1-yß-D-arabinofuranosylcytosine 5'-triphos-phate, were found in amounts of 0.41, 0.37, 0.17, and 0.05%, respectively, of the total drug found in the cells. Also found were the inactive metabolites 1-ß-D-arabinofuranosyluracil and 1-y3-D-arabinofuranosylcytosine diphosphate choline in amounts of 0.61 and 0.29%, respectively.

[1]  R. Minchin,et al.  Chlorphentermine binding in rat lung subcellular fractions and its displacement by desmethylimipramine. , 1979, Biochemical pharmacology.

[2]  M. Bickel,et al.  Interactions of chlorpromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. , 1979, Biochemical pharmacology.

[3]  T. Tsuruo,et al.  Comparison of cytotoxic effect and cellular uptake of 1-beta-D-arabinofuranosylcytosine and its N4-acyl derivatives, using cultured KB cells. , 1979, Cancer research.

[4]  A. Lee,et al.  Effects of charged drugs on the phase transition temperatures of phospholipid bilayers. , 1978, Biochimica et biophysica acta.

[5]  R. Wohlhueter,et al.  Transport and metabolism of deoxycytidine and 1-beta-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. , 1978, Cancer research.

[6]  T. Chou,et al.  Metabolism of 1- β -d-Arabinofuranosylcytosine in Human Leukemic Cells , 1977 .

[7]  T. Ishida,et al.  N4-Behenoyl-1-β-d-arabinofuranosylcytosine as a Potential New Antitumor Agent , 1977 .

[8]  P. McNamara,et al.  Tissue binding of drugs. , 1977, Journal of pharmaceutical sciences.

[9]  T. Ishida,et al.  N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent. , 1977, Cancer research.

[10]  T. Ishida,et al.  Antitumor activities of newly synthesized N4-acyl-1-beta-D-arabinofuranosylcytosine. , 1976, Cancer research.

[11]  T. Yamashita,et al.  Adenovirus deoxyribonucleic acid replication. II. Synthesis of viral deoxyribonucleic acid in vitro by a nuclear membrane fraction from infected KB cells. , 1975, The Journal of biological chemistry.

[12]  T. Chou,et al.  Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo. , 1975, Cancer research.

[13]  R. Momparler,et al.  A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine. , 1974, Cancer research.

[14]  D. Ho Distribution of kinase and deaminase of 1-beta-D-arabinofuranosylcytosine in tissues of man and mouse. , 1973, Cancer research.

[15]  K. Kikugawa,et al.  Studies on the Vilsmeier-Haack Reaction. III. Synthesis of Cytidine Diphosphate Choline , 1971 .

[16]  C. D. Steuart,et al.  Cytidine deaminase and the development of resistance to arabinosyl cytosine. , 1971, Nature: New biology.

[17]  H. Skipper,et al.  Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. , 1967, Cancer chemotherapy reports.

[18]  M. M. Nass,et al.  Membranes of animal cells. I. Methods of isolation of the surface membrane , 1966 .

[19]  A. Goldin,et al.  Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules. , 1966, Cancer research.